Portugal J, Sánchez-Baeza F J
Departamento de Biología Molecular y Celular, Centro de Investigación y Desarrollo, CSIC, Barcelona, Spain.
Biochem J. 1995 Feb 15;306 ( Pt 1)(Pt 1):185-90. doi: 10.1042/bj3060185.
Poly[d(G-m5C)] was modified by reductively activated mitomycin C, an anti-tumour drug, under buffer conditions which are known to favour either the B or the Z conformations of DNA. C.d. and 31P-n.m.r. were used to characterize the poly[d(G-m5C)]-mitomycin cross-linked complexes, as well as the effects on the equilibrium between the B and Z forms of the polynucleotide. Mitomycin C appears to inhibit the B-->Z transition, even in the presence of 3 mM MgCl2, while the Z-form of poly[d(G-m5C)] does not interact significantly with the drug under bifunctionally activating conditions; thus no reversion from the Z-form to the B-form of the polynucleotide can be observed under the salt conditions which are required for the Z-form to exist.
在已知有利于DNA的B型或Z型构象的缓冲条件下,抗肿瘤药物丝裂霉素C经还原活化后修饰了聚[d(G - m5C)]。利用圆二色光谱(C.d.)和31P核磁共振(31P - n.m.r.)对聚[d(G - m5C)] - 丝裂霉素交联复合物进行表征,以及研究其对多核苷酸B型和Z型之间平衡的影响。丝裂霉素C似乎能抑制B型向Z型的转变,即使在存在3 mM MgCl2的情况下也是如此,而在双功能活化条件下,聚[d(G - m5C)]的Z型与该药物没有显著相互作用;因此,在Z型存在所需的盐条件下,未观察到多核苷酸从Z型向B型的逆转。